GO
Loading...

When drug costs become too cheap

Thursday, 22 May 2014 | 12:44 PM ET

CNBC biotech and pharmaceutical reporter Meg Tirrell discusses what happens on the flip-side of high health-care costs—when antibiotic costs become too low and stifle development.